Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Profound Medical Corp    PRN   CA74319B1067

PROFOUND MEDICAL CORP

(PRN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
1.1(c) 1.07(c) 1.05(c) 1.06(c) 1.16(c) Last
149 747 293 039 258 806 214 457 448 160 Volume
0.00% -2.73% -1.87% +0.95% +9.43% Change
More quotes
Financials (CAD)
Sales 2019 5,87 M
EBIT 2019 -19,0 M
Net income 2019 -19,5 M
Debt 2019 -
Yield 2019 -
Sales 2020 16,4 M
EBIT 2020 -19,6 M
Net income 2020 -15,6 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -6,43x
P/E ratio 2020 -8,18x
Capi. / Sales2019 23,1x
Capi. / Sales2020 8,30x
Capitalization 136 M
More Financials
Company
Profound Medical Corp., formerly Mira IV Acquisition Corp., is a capital pool company. The Company is a medical device company focused on prostate cancer care. Its product consists of common electronic components, capital equipment and disposables. The Company is developing and commercializing a... 
More about the company
Surperformance© ratings of Profound Medical Corp
Trading Rating : Investor Rating : -
More Ratings
Latest news on PROFOUND MEDICAL CORP
09/12PROFOUND MEDICAL : Announces Proposed Offerings of Units
AQ
08/16Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO®
GL
08/15Accomplished Financial Executive, Steve Forte, Joins Profound Medical's Board
GL
08/14Profound Medical Announces Second Quarter 2019 Financial Results
GL
07/31Profound Medical to Present at the Canaccord Genuity 39th Annual Growth Confe..
GL
07/30Profound Medical to Release Second Quarter 2019 Financial Results on August 1..
GL
07/09Profound Medical Sells First TULSA-PRO® System in Japan
GL
06/13Profound Medical Annual and Special Meeting of Shareholders Voting Results
GL
05/06Profound Medical Announces First Quarter 2019 Financial Results
GL
04/23PROFOUND MEDICAL : to Present at the 2019 Bloom Burton & Co. Healthcare Investor..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/19ROYAL PHILIPS : Philips to sell remaining 10.7% stake in Signify for 357 million..
RE
09/18Sony Rejects Investor's Call to Spin Off Profitable Unit -- WSJ
DJ
09/17ROYAL PHILIPS : Trade wars, Brexit are 'profit warning', Dutch king says
RE
09/17DANIEL LOEB : Sony rejects Loeb's proposal for chip business spin-off
RE
09/11Dutch government to trim multinational tax deductions - NOS
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PROFOUND MEDICAL CORP
Duration : Period :
Profound Medical Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROFOUND MEDICAL CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 2,95  CAD
Last Close Price 1,16  CAD
Spread / Highest target 245%
Spread / Average Target 154%
Spread / Lowest Target 63,8%
EPS Revisions
Managers
NameTitle
Arun S. Menawat Chief Executive Officer & Non-Independent Director
Damian Lamb Chairman
Aaron Davidson CFO & Senior VP-Corporate Development
Jean-François Pariseau Independent Director
William Edward Curran Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PROFOUND MEDICAL CORP110.91%102
THERMO FISHER SCIENTIFIC32.41%118 240
DANAHER CORPORATION42.04%104 556
INTUITIVE SURGICAL10.91%61 021
BOSTON SCIENTIFIC CORPORATION22.50%59 981
ILLUMINA, INC.3.21%44 864